This list is an analysis based on recent market events. It's not an investment recommendation.
About
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.
The current price of W1H.MU is €0.14 EUR — it has decreased by -22.36% in the past 24 hours. Watch Onco Innovations stock price performance more closely on the chart.
What is Onco Innovations stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Onco Innovations stocks are traded under the ticker W1H.MU.
What is Onco Innovations market cap?▼
Today Onco Innovations has the market capitalization of 9.44M
What is Onco Innovations revenue for the last year?▼
Onco Innovations revenue for the last year amounts to 68,490.21 EUR.
What is Onco Innovations net income for the last year?▼
W1H.MU net income for the last year is -6.72M EUR.
In which sector is Onco Innovations located?▼
Onco Innovations operates in the Health & Wellness sector.
When did Onco Innovations complete a stock split?▼
Onco Innovations has not had any recent stock splits.
Where is Onco Innovations headquartered?▼
Onco Innovations is headquartered in Calgary, Canada.